Levocetirizina Aurovitas Spain (Levocetirizine Dihydrochloride)

Levocetirizine works by selectively blocking peripheral histamine H1 receptors. This prevents histamine released during allergic reactions from binding to its receptors, thereby inhibiting the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation, which are responsible for typical allergy symptoms.

The specific dose is determined by the prescribing healthcare professional based on the patient’s age, condition severity and renal function. In clinical practice, an adult dose is often 5 mg once daily, but the exact regimen should always follow the prescriber’s instructions.

Safety data in pregnancy and lactation are limited. Levocetirizine should only be used during pregnancy or while breastfeeding if the potential benefit justifies the potential risk to the fetus or infant. Patients should discuss any concerns with their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is the active enantiomer of cetirizine, offering similar efficacy with a potentially lower incidence of sedation. Compared with first‑generation antihistamines, it provides rapid symptom relief while causing less drowsiness. It is also more selective for H1 receptors than many second‑generation agents, which may translate into a favorable safety profile.

Store the product at ambient temperature below 25 °C. Keep the tablets in the original blister pack or container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

The medication is taken orally, usually as a tablet, with a glass of water. It can be taken with or without food, and the dose should be swallowed whole; crushing or chewing the tablet is not recommended.

Serious adverse reactions, although rare, include anaphylaxis, angioedema (swelling of the face, lips or tongue) and severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. Immediate medical attention is required if any of these symptoms occur.

Patients with a known hypersensitivity to levocetirizine or any of the tablet’s excipients should avoid the product. Those with severe renal impairment may require dose adjustment or alternative therapy, and individuals taking interacting CNS depressants should be monitored closely for excessive sedation.